| Literature DB >> 35116648 |
Yi-Chen Tang1, Qin-Qin Liu1, Yong-Gang He1, Jing Li1, Xiao-Bing Huang1.
Abstract
BACKGROUND: Laparoscopic pancreaticoduodenectomy (LPD) is widely used in several centers. This study analyzed the postoperative complications rate curve, possible cause, and solution of LPD and open pancreaticoduodenectomy (OPD).Entities:
Keywords: Pancreaticoduodenectomy; learning curve; postoperative complications
Year: 2021 PMID: 35116648 PMCID: PMC8798474 DOI: 10.21037/tcr-21-518
Source DB: PubMed Journal: Transl Cancer Res ISSN: 2218-676X Impact factor: 1.241
Figure 1Eight-step laparoscopic operative technique. (A) Exposure and stripping of the pancreatic head; (B) exposure of pancreas and gastrectomy; (C) dissection of porta hepatis; (D) resection of the uncinate process; (E) reconstruction of the pancreaticojejunostomy; (F) reconstruction of hepaticojejunostomy; (G) reconstruction of gastrojejunostomy; (H) placement of the drainage system and closure of the incision.
Clinicopathological characteristics of patients (n=417)
| Characteristics | OPD (n=213) | LPD (n=204) | P value |
|---|---|---|---|
| Age, mean ± SD, y | 56.42±1.07 | 58.37±0.88 | 0.159 |
| Sex, n (%) | |||
| Male | 130 (61.0) | 120 (58.8) | |
| Female | 83 (38.9) | 84 (41.2) | 0.645 |
| BMI, mean ± SD | 1.616±0.015 | 1.582±0.019 | 0.171 |
| Abdominal surgery in medical history, n (%) | 52 (24.4) | 36 (17.9) | 0.016* |
| ASA physical status, n (%) | |||
| 1 | 52 (24.4) | 66 (32.4) | |
| 2 | 127 (59.6) | 110 (53.9) | |
| 3 | 34 (16.0) | 28 (13.7) | 0.229 |
| Symptoms, n (%) | |||
| Abdominal pain, n (%) | 145 (68.1) | 151 (74.0) | 0.181 |
| Jaundice, n (%) | 143 (67.1) | 127 (62.3) | 0.297 |
| General weakness, n (%) | 31 (14.6) | 20 (9.8) | 0.139 |
| Tumor size on imaging, mean ± SD, mm | 26.68±1.34 | 24.01±1.01 | 0.110 |
| Preoperative biliary drainage, n (%) | 67 (31.5) | 77 (37.7) | 0.177 |
| Endoscopic retrograde biliary drainage, n (%) | 13 (6.1) | 7 (3.4) | 0.202 |
| Percutaneous transhepatic cholangial drainage, n (%) | 54 (25.4) | 70 (34.3) | 0.045* |
| High risk for postoperative pancreatic fistula, n (%) | 46 (21.6) | 52 (25.5) | 0.348 |
| PDAC patients, n (%) | 99 (46.5) | 76 (37.3) | 0.056 |
Data are mean ± SD and n (%). *, P<0.05 as statistically significant. OPD, open pancreaticoduodenectomy; LPD, laparoscopic pancreaticoduodenectomy; SD, standard deviation; BMI, body mass index; ASA, American Society of Anesthesiology; PDAC, pancreatic ductal adenocarcinoma.
Operative outcomes and histopathological characteristics
| Clinical characteristics | OPD (n=213) | LPD (n=204) | P value |
|---|---|---|---|
| Operative time, mean ± SD, min | 378.7±8.98 | 402.5±7.12 | 0.037* |
| 51–204 cases: operative time, mean ± SD, min | 375.3±9.31 | 384.7±6.42 | 0.459 |
| Pancreaticoduodenectomy time, mean ± SD, min | 256.5±8.31 | 287.4±6.56 | 0.004* |
| Pancreaticojejunostomy time, mean ± SD, min | 29.35±0.41 | 33.81±0.50 | <0.001* |
| Hepaticojejunostomy time, mean ± SD, min | 24.81±0.48 | 25.47±0.47 | 0.313 |
| Gastrojejunostomy time, mean ± SD, min | 23.82±0.41 | 24.84±0.40 | 0.072 |
| Drainage placement and closure time, mean ± SD, min | 48.33±0.50 | 24.32±0.70 | <0.001* |
| Estimated blood loss, mean ± SD, mL | 530.1±33.55 | 389.9±19.05 | <0.001* |
| Tumor size (mm) | 24.95±1.30 | 22.06±0.88 | 0.062 |
| Pancreas duct size (mm) | 4.29±0.13 | 4.08±0.13 | 0.271 |
| Pancreas texture (soft:hard) | 113 (53.1):100 | 127 (62.3):77 | 0.057 |
| Pathological diagnosis, n (%) | 0.094 | ||
| PDAC | 87 (40.8) | 60 (29.4) | |
| Neuroendocrine tumor | 6 (2.8) | 8 (3.9) | |
| Intraductal papillary mucinous neoplasm | 13 (6.1) | 9 (4.4) | |
| Common bile duct cancer | 53 (24.9) | 52 (25.6) | |
| Ampulla of Vater cancer | 31 (14.6) | 46 (22.5) | |
| Others | 23 (10.8) | 29 (14.2) | |
| Bile duct size (mm) | 13.38±0.40 | 14.24±0.39 | 0.132 |
| Margin status (R0:R1) | 188 (88.3):25 | 190 (93.1):14 | 0.087 |
| LN harvest, mean ± SD, n (%) | 10.69±0.51 | 10.84±0.41 | 0.818 |
| Vascular resection, n (%) | 22 (10.3) | 14 (6.9) | 0.208 |
| Malignancy, n (%) | 170 (79.8) | 175 (85.8) | 0.107 |
| Conversion from laparoscopy to open, n (%) | – | 14 (6.9) |
Data are mean ± SD and n (%). *, P<0.05 as statistically significant. Others include spindle cell tumors, duodenal cancer, ampulla of Vater adenoma, solid pseudopapillary tumor. OPD, open pancreaticoduodenectomy; LPD, laparoscopic pancreaticoduodenectomy; SD, standard deviation; PDAC, pancreatic ductal adenocarcinoma; LN, lymph node.
Postoperative complications
| Postoperative complications | OPD (n=213) | LPD (n=204) | P value |
|---|---|---|---|
| Clavien-Dindo Classification, n (%) | |||
| <3 | 196 (92.0) | 186 (91.2) | |
| ≥3 | 17 (8.0) | 18 (8.8) | 0.757 |
| Surgical re-intervention, n (%) | 7 (3.3) | 6 (2.9) | 0.840 |
| Pancreatic fistula (B/C), n (%) | 16 (7.5) | 14 (6.9) | |
| B | 13 (6.1) | 10 (4.9) | |
| C | 3 (1.4) | 4 (2.0) | 0.815 |
| Biliary-enteric anastomosis leakage, n (%) | 1 (0.5) | 6 (2.9) | 0.049* |
| Post-pancreatectomy site hemorrhage, n (%) | 22 (10.3) | 12 (5.9) | 0.097 |
| Gastrointestinal hemorrhage, n (%) | 21 (9.9) | 21 (10.3) | 1.000 |
| Intraperitoneal infection, n (%) | 21 (9.9) | 19 (9.3) | 0.850 |
| Lung infection, n (%) | 37 (17.4) | 15 (7.4) | 0.037* |
| Incision infection, n (%) | 18 (8.5) | 2 (1.0) | <0.001* |
| Anal exhaust time, mean ± SD, day | 4.05±0.07 | 3.35±0.07 | <0.001* |
| Delayed gastric emptying, n (%) | 21 (9.9) | 34 (16.7) | 0.035* |
| Postoperative hospital stay, mean ± SD, day | 13.48±0.56 | 12.91±0.65 | 0.314 |
Data are mean ± SD and n (%). *, P<0.05 as statistically significant. OPD, open pancreaticoduodenectomy; LPD, laparoscopic pancreaticoduodenectomy; SD, standard deviation.
Chi-square test was used to analyze the correlation between Clavien-Dindo Classification ≥3 and severe postoperative complications
| Postoperative complications | Clavien-Dindo Classification <3 (n=186) | Clavien-Dindo Classification ≥3 (n=18) | P value |
|---|---|---|---|
| Pancreatic fistula (B/C), n | 11 | 3 | 0.085 |
| Post-pancreatectomy site hemorrhage, n | 10 | 2 | 0.323 |
| Gastrointestinal hemorrhage, n | 20 | 1 | 0.449 |
| Intraperitoneal infection, n | 10 | 9 | <0.001 |
| Biliary-enteric anastomosis leakage, n (%) | 1 (8.2) | 5 (20.6) | <0.001 |
P<0.001 as statistically significant.
Bootstrap replications in the univariate analyses of the factors related to clinically relevant postoperative delayed gastric emptying (n=34) following LPD
| Clinical characteristics | Control (n=170) | Delayed gastric emptying (n=34) | OR (95% CI) | P value |
|---|---|---|---|---|
| Operative time, mean ± SD, min | 396.1±7.66 | 429.3±17.3 | 0.081 | |
| Estimated blood loss, mean ± SD, mL | 386.7±22.43 | 451.4±45.30 | 0.237 | |
| Clavien-Dindo Classification, n (%) | ||||
| <3 | 156 (91.8) | 27 (79.4) | ||
| ≥3 | 14 (8.2) | 7 (20.6) | 2.889 (1.068–7.814) | 0.030* |
| Postoperative activities, n (%) | ||||
| ≤3 days | 64 (37.6) | 15 (44.1) | ||
| >3 days | 106 (63.4) | 19 (55.9) | 0.500 | |
| Postoperative albumin, n (%) | ||||
| <35 mmol/L | 81 (47.6) | 17 (50.0) | ||
| >35 mmol/L | 89 (52.4) | 17 (50.0) | 0.802 | |
| Postoperative pain score, n (%) | ||||
| ≤3 | 132 (77.6) | 21 (61.8) | ||
| >3 | 38 (22.4) | 13 (38.2) | 0.051 | |
| Procalcitonin, n (%) | ||||
| <0.25 mmol/L | 91 (53.5) | 17 (50.0) | ||
| ≥0.25 mmol/L | 79 (46.5) | 17 (50.0) | 0.706 | |
| Pull out the stomach tube, n (%) | ||||
| <3 days | 13 (7.6) | 20 (58.8) | ||
| ≥3 days | 157 (92.4) | 14 (41.2) | 0.058 (0.024–0.141) | <0.001* |
| Pancreatic fistula (B/C), n (%) | 3 (1.8) | 11 (32.4) | 1.452 (1.150–1.834) | <0.001* |
Data are mean ± SD and n (%). *, P<0.05 as statistically significant. LPD, laparoscopic pancreaticoduodenectomy; OR, odds ratio; CI, confidence interval; SD, standard deviation.
Figure 2Kaplan-Meier survival curve of patients with PDAC. PDAC, pancreatic ductal adenocarcinoma; OPD, open pancreaticoduodenectomy; LPD, laparoscopic pancreaticoduodenectomy; MD, mean difference.
Figure 3CUSUM analysis the major postoperative complication rate for LPD. (A) CUSUM analysis of pancreatic fistula rate for LPD; (B) CUSUM analysis of biliary-enteric anastomosis leakage rate for LPD; (C) CUSUM analysis of ≥3 of Clavien-Dindo Classification a rate for LPD. The black line is fitted curve. CUSUM, cumulative sum; LPD, laparoscopic pancreaticoduodenectomy.
Figure 4CUSUM analysis of operative time for LPD (the black line is fitted curve). (I) Period 1: study (1–61 cases); (II) period 2: accumulation (62–86 cases). If the slope K is negative from case 87, it indicates the start of period 3 (87–200 cases); (III) period 3: the operative time for complete lymph node dissection, vein resection, or pancreatic head tumor resection tends to be lower than the mean operative time. The black line is fitted curve. CUSUM, cumulative sum; LPD, laparoscopic pancreaticoduodenectomy.